title: Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?
authors.affiliation: aUniversity of Michigan, Ann Arbor bUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: W Joseph
authors.initials: WJ
authors.lastname: McCune
authors.forename: Tania
authors.initials: T
authors.lastname: Gonzalez-Rivera
mesh_terms: D000962:Antimalarials / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005128:Eye Diseases / Q000139:chemically induced / Q000517:prevention & control*; D005500:Follow-Up Studies; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011796:Quinacrine / Q000008:administration & dosage*; D012074:Remission Induction; D013997:Time Factors
chemical_list: D000962:Antimalarials; D006886:Hydroxychloroquine; D011796:Quinacrine